Details of the Drug Reposition
General Information of This Drug (ID: DM3OBQF)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms | Belimumab (USAN); LymphoStat-B; LymphoStat-B (TN) | |||||
| Drug Type |
Antibody
|
|||||
Information on Drug Reposition of This Drug
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2 Approved Indication(s)
|
|
||||||||||||||||||||||||||||||
|
1 Discontinued in Phase 2 Indication(s)
|
|
||||||||||||||||||||||||||||||
References
